Who we are

Nerviano Medical Sciences (NMS) is the largest pharmaceutical R&D facility in Italy and one of the largest oncology-focused, integrated discovery and development companies in Europe. NMS was incorporated in May 2004 following company re-organisation by Pfizer.

A total of almost 650 highly skilled and experienced scientists, technicians and managers are involved in oncology R&D projects from target validation through to clinical phase IIa.

Our aim is to discover and develop innovative medicines for the treatment of cancer and set up partnerships with the biopharmaceutical industry and the scientific community.

Preclinical and pharmaceutical development services are made available to drug companies and biotechs worldwide.

NervianoMS is a private company owned by the Congregazione dei Figli dell'Immacolata Concezione (CFIC). Financial resources and the establishing of long term strategies are managed by CFIC.